Clinical trial
Radiation Therapy Plus Combination Chemotherapy in Treating Children With…
NCT00053872 · University of Leicester, Other · Unknown status
Key facts
| NCT number | NCT00053872 |
|---|---|
| Title | Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma |
| Official title | A Prospective Randomised Controlled Trial Of Hyperfractionated Versus Conventionally Fractionated Radiotherapy In Standard Risk Medulloblastoma |
| Lead sponsor | University of Leicester, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cisplatin, lomustine, vincristine sulfate, adjuvant therapy, radiation therapy |
| Enrollment | 316 |
| Start date | Feb 1, 2003 |
| First posted | Feb 6, 2003 |
| Last update posted | Jun 24, 2014 |
| Countries | Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: